Healthcare >> Analyst Interviews >> June 7, 2001

Biotechnology Overview: Franklin Berger – Jp Morgan H&q

FRANKLIN M. BERGER is a Managing Director in the US Equity Research Department of J. P. Morgan H & Q, having joined the firm in 1998. He is a Senior Biotechnology Analyst and part of the Global Health Care Research team. He received his MBA from Harvard University and both his MA and BA degrees from Johns Hopkins University. In 2000, he became a Founding Fellow of the Biotechnology Study Center at New York University School of Medicine. Profile
TWST: Can you give me a brief overview of your coverage area?

Mr. Berger: We cover high value human therapeutic companies. To give you

an idea of the type of companies we cover, let me list